C. Clary

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

Jean‐Yves Douillard, Rafael Rosell, Mario De Lena et al. · The Lancet Oncology · 2006 · 1.6K citations

Medicine, Oncology, Pharmacology +12

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

Jean-Louis Pujol, Jean-Luc Breton, R. Gervais et al. · Annals of Oncology · 2005 · 131 citations · Full text

Medicine, Oncology, Pharmacology +16

Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study

Jean‐Yves Douillard, R. Gervais, G Dabouis et al. · Annals of Oncology · 2004 · 37 citations

Medicine, Oncology, Pharmacology +17

Metastatic carcinoma: The lung as the site for the clinically undiagnosed primary

C. Clary, René P. Michel, Nai‐San Wang et al. · Cancer · 1983 · 15 citations · Full text

Medicine, Oncology, Pathology +15